All Articles

ElevateBio's new COO, Steven Falcone, is a strategic weapon against the crushing cost of advanced therapy manufacturing. This isn't just a hire; it's a war on the price of miracles.

A landmark report reveals arthritis isn't just a health issue; it's a massive economic drain poised to grow, costing Canada nearly 5% of its GDP annually.

A top general joins a defense AI firm, promising to revolutionize military readiness. But does the well-trod path from battlefield to boardroom accelerate innovation or just grease the wheels of the military-industrial complex?

Private equity firm Great Hill Partners backs insurtech MGA Aurenity, betting that AI-driven underwriting is the key to mastering the complex E&S market.

Adicet Bio nears a pivotal data readout for its lupus CAR-T, now viable for outpatient use, while launching a novel solid tumor attack in prostate cancer.

Beyond the pink ribbons, the CIBC Run for the Cure is a funding powerhouse. We unpack the 30-year alliance that's fueling AI-driven diagnostics and policy battles.

As Iron Mountain executives prepare for key tech conferences, they aren't just presenting financials; they're selling a new identity as a data infrastructure leader.

With its acquisition of TEAM Companies, DISA is betting on specialized tech to manage the risks of an expanding contractor workforce in high-stakes industries.

With Hepatitis C royalties declining, Enanta Pharmaceuticals faces investors this month to sell its vision: a future built on novel RSV and immunology drugs.

In an age of deepfakes, a leading AI firm is launching a podcast on... ancient history. Sumsub's 'Trust Forward' bets our future depends on the past.

An estimated 13 million Americans live with Dupuytren's contracture, a progressive hand condition. A new campaign using mixed reality aims to change that.

Regis Corp reports mixed FY26 results, but a deeper dive reveals a strategic turnaround. With operational gains and a key debt battle, is the salon giant set for growth?

As enterprises grapple with AI risks, a new platform puts them back in control. Airrived's Sovereign AI promises security, predictability, and autonomy.

A new public-private alliance aims to fast-track critical diagnostics and medical devices, bridging the gap between innovation and emergency preparedness.

With a $700M partnership, Medtronic isn't just buying another robot. It's building a flexible surgical ecosystem to challenge market dominance globally.

As Weltrade marks two decades, its new risk-free World Cup tests trader skill, proprietary tech, and the power of algorithms in a synthetic arena.

A new report reveals a productivity crisis fueled by financial stress. For leaders, ignoring employee financial health is no longer a viable option.

With 6 million Canadians affected and a growing specialist shortage, a new campaign aims to double donations to fund the research and care a system can't provide.

A new survey finds 3 in 4 California grads say their degree was worth it, but not for the reasons you'd think. The data reveals a complex picture of success.

As AI agents begin to manage our finances, EMVCo has unveiled a new framework to ensure they act on our behalf. Can 'Intent Services' build trust?